Neoplasms by Histologic Type
Showing 1 - 25 of >10,000
Orelabrutinib in Combination With Standard Treatment Regimen for
Not yet recruiting
- Lymphoma, Large B-Cell, Diffuse Neoplasms by Histologic Type
-
Nanjing, Jiangsu, ChinaHematological Department, People's Hospital of Jiangsu Province
Aug 23, 2023
Respiratory Tract Diseases, Tumors, Tumors by Histologic Type Trial run by the National Cancer Institute (NCI) (Bevacizumab)
Not yet recruiting
- Respiratory Tract Diseases
- +14 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 10, 2023
Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Tumors Germ Cell and Embryonal Tumors by Histologic Type Tumors Tumors
Not yet recruiting
- Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms
- HX008 + TACE
- +2 more
-
Beijing, Beijing, ChinaBeijing Cancer hospital
Dec 8, 2022
Lymphoma, Lymphoma, Non-Hodgkin, Immune System Diseases Trial in Chapel Hill (ATLCAR.CD30 cells)
Recruiting
- Lymphoma
- +7 more
- ATLCAR.CD30 cells
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Dec 2, 2022
Dupuytren Contracture, Dupuytren's Disease, Contracture Trial (procedure, drug, other)
Not yet recruiting
- Dupuytren Contracture
- +11 more
- Percutaneous needle fasciotomy
- +2 more
- (no location specified)
Jun 30, 2022
Cervical Intraepithelial Neoplasia Grade 2/3, Tumor Cervix, Carcinoma in Situ Trial in Milan (Self-Collecting Devices, In Vitro
Completed
- Cervical Intraepithelial Neoplasia Grade 2/3
- +5 more
- Self-Collecting Devices
- In Vitro Diagnostic Assays
-
Dublin, Ireland
- +5 more
Jan 5, 2023
Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Placebo)
Completed
- Neoplasms
- +14 more
- Entinostat
- Placebo
-
San Antonio, TexasThe START Center for Cancer Care
Apr 21, 2022
Lung Tumor Malignant, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-451)
Recruiting
- Lung Neoplasm Malignant
- +18 more
-
Fairfax, VirginiaNew Experimental Therapeutics of Virginia (NEXT Oncology)
Mar 29, 2022
Esophageal Squamous Cell Carcinoma, Esophageal Tumors, Esophageal Diseases Trial (Anlotinib HCl, TQB2450)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- +10 more
- Anlotinib hydrochloride
- TQB2450
- (no location specified)
Feb 19, 2022
Lymphoma, Lymphoma, Mantle-Cell, Tumors by Histologic Type Trial (IM19 CAR-T cells, Cyclophosphamide, Fludarabine)
Not yet recruiting
- Lymphoma
- +4 more
- IM19 CAR-T cells
- +2 more
- (no location specified)
Nov 30, 2021
Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T
Active, not recruiting
- Prostatic Neoplasms, Castration-Resistant
- +16 more
- P-PSMA-101 CAR-T cells
- Rimiducid
-
Duarte, California
- +9 more
Nov 15, 2022
Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin Trial in Chapel Hill, Winston-Salem (ATLCAR.CD30 cells)
Active, not recruiting
- Hodgkin Disease
- +8 more
- ATLCAR.CD30 cells
-
Chapel Hill, North Carolina
- +1 more
Mar 2, 2022
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)
Recruiting
- Leukemia
- +19 more
- CYNK-001
-
Denver, Colorado
- +9 more
Sep 9, 2022
Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Pembrolizumab)
Completed
- Neoplasms
- +13 more
-
San Antonio, TexasThe START Center for Cancer Care
Jan 24, 2022
Lymphoma, Large B-Cell, Diffuse, Tumors by Histologic Type Trial in China (penpulimab, lenalidomide, Rituximab, Gemcitabine,
Not yet recruiting
- Lymphoma, Large B-Cell, Diffuse
- Neoplasms by Histologic Type
- penpulimab, lenalidomide, Rituximab, Gemcitabine, Oxaliplatin
-
Hefei, Anhui, China
- +3 more
Mar 3, 2022
Multiple Myeloma, Tumor, Plasma Cell, Tumors by Histologic Type Trial in United States (CYNK-001)
Active, not recruiting
- Multiple Myeloma
- +19 more
- CYNK-001
-
Denver, Colorado
- +8 more
May 24, 2022
Uterine Cervical Tumors, Uterine Cervical Cancer, Tumors, Squamous Cell Trial in Seattle (BD SurePath Plus Pap test, BD SurePath
Terminated
- Uterine Cervical Neoplasms
- +6 more
- BD SurePath Plus Pap test
- +3 more
-
Seattle, WashingtonSeattle Women's: Health, Research, Gynecology
Apr 12, 2021
Oropharynx Cancer, Oropharynx Squamous Cell Carcinoma, Carcinoma, Squamous Cell Trial in Aarhus, Copenhagen, Odense (radiation,
Recruiting
- Oropharynx Cancer
- +18 more
- Intensity-Modulated Radiation Therapy (IMRT)
- +3 more
-
Aarhus, Denmark
- +2 more
Sep 28, 2021